Creating new ultrasound techniques to improve imaging in type 1 diabetes
Developing ultrasound contrast agents and signal processing for structural and functional imaging in type 1 diabetes
This study is working on new ultrasound techniques to help doctors get a clearer picture of the pancreas in people with type 1 diabetes, which could lead to better ways to monitor and manage the condition.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Colorado Denver NIH-funded |
| Lab location | 1 site (Aurora, UNITED STATES) |
| Project ID | NIH-11099943 on NIH RePORTER |
What this research studies
This research focuses on developing advanced ultrasound contrast agents and signal processing methods to enhance imaging of the pancreas in individuals with type 1 diabetes. By improving the ability to visualize blood flow and the structural integrity of pancreatic tissues, the research aims to provide better insights into the disease's progression and complications. Patients may benefit from more accurate imaging techniques that can lead to improved monitoring and management of their condition. The approach combines innovative technology with clinical applications to address the challenges faced by those living with diabetes.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with type 1 diabetes who require advanced imaging techniques for better disease management.
Not a fit: Patients with type 2 diabetes or those without any form of diabetes may not receive benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective monitoring and treatment strategies for patients with type 1 diabetes.
How similar studies have performed: Previous research has shown promise in using advanced imaging techniques for diabetes management, indicating potential success for this novel approach.
Where this research is happening
Aurora, UNITED STATES
- University of Colorado Denver — Aurora, United States (Active)
Researchers
- Principal investigator: Benninger, Richard Kp — University of Colorado Denver
- Study coordinator: Benninger, Richard Kp
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.